Naptumomab Estafenatox (TPBG) Antibody, Monoclonal
| Code | Size | Price |
|---|
| PSI-10-087-0.1mg | 0.1mg | £657.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: Fab-G1-kappa
Antibody Clonality: Recombinant Antibody
Regulatory Status: RUO
Shipping:
blue ice
Storage:
Store at -80˚C
Documents
Further Information
Additional Names:
ABR-217620,ANYARA,TTS CD3, TPBG, TPBG
Background:
Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.
Buffer:
PBS buffer pH7.5
Concentration:
batch dependent
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
Mus musculus / TPBG [Homo sapiens]
NCBI Organism:
homo sapiens
Purification:
>95%
Research Area:
Drug Analogues
Source:
CHO cells
Specificity:
Please note: 10-087 is the pure recombinant antibody Naptumomab without Estafenatox fragment. The original antibody drug is the fusion protein ?Naptumomab + Estafenatox?, however, the research grade biosimilar we can supply is the recombinant antibody without any conjugation or any fragment.
User NOte:
Optimal dilutions for each application to be determined by the researcher.